Abstract:Background and aims:<bold> </bold>Dynamic evaluation of critically ill patients is the key to predicting their outcomes. Most scores based on the Model for End-stage Liver Disease (MELD) and acute-on-chronic liver failure (ACLF) utilize point-in-time assessment. This study mainly aimed to investigate the impact of dynamic clinical course change on post-liver transplantation (LT) survival.Methods:<bold> </bold>This study included 637 adults (overall cohort) with benign end-stage liver diseases. The authors compared the MELD scores and our ACLF-based dynamic evaluation scores. Patients enrolled or transplanted with ACLF-3 were defined as the ACLF-3 cohort ( n =158). The primary outcome was 1-year mortality. Delta MELD and Delta CLIF-OF (Chronic Liver Failure-Organ Failure) represented the respective dynamic changes in liver transplant function. Discrimination was assessed using the area under the curve. A Cox regression analysis identified independent risk factors for specific organ failure and 1-year mortality.Results:<bold> </bold>Patients were grouped into three groups: the deterioration group (D), the stable group (S), and the improvement group (I). The deterioration group (Delta CLIF-OF >= 2) was more likely to receive national liver allocation ( P =0.012) but experienced longer cold ischemia time ( P =0.006) than other groups. The area under the curves for Delta CLIF-OF were 0.752 for the entire cohort and 0.767 for ACLF-3 cohorts, both superior to Delta MELD ( P <0.001 for both). Compared to the improvement group, the 1-year mortality hazard ratios (HR) of the deterioration group were 12.57 (6.72-23.48) for the overall cohort and 7.00 (3.73-13.09) for the ACLF-3 cohort. Extrahepatic organs subscore change (HR=1.783 (1.266-2.512) for neurologic; 1.653 (1.205-2.269) for circulation; 1.906 (1.324-2.743) for respiration; 1.473 (1.097-1.976) for renal) were key to transplantation outcomes in the ACLF-3 cohort. CLIF-OF at LT (HR=1.193), Delta CLIF-OF (HR=1.354), and cold ischemia time (HR=1.077) were independent risk factors of mortality for the overall cohort, while Delta CLIF-OF (HR=1.384) was the only independent risk factor for the ACLF-3 cohort. Non-ACLF-3 patients showed a higher survival rate than patients with ACLF-3 in all groups ( P =0.002 for I, P =0.005 for S, and P =0.001 for D).Conclusion:<bold> </bold>This was the first ACLF-based dynamic evaluation study. Delta CLIF-OF was a more powerful predictor of post-LT mortality than Delta MELD. Extrahepatic organ failures were core risk factors for ACLF-3 patients. CLIF-OF at LT, Delta CLIF-OF, and cold ischemia time were independent risk factors for post-LT mortality. Patients with a worse baseline condition and a deteriorating clinical course had the worst prognosis. Dynamic evaluation was important in risk stratification and recipient selection.

[Clinical Evaluation of Emergency Liver Transplantation for Patients with Benign End-Stage Liver Diseases].

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

Therapeutic Evaluation of the Patients with High MELD Scores Undergoing Liver Transplantation for Benign End-Stage Liver Disease

[Review of Risk Evaluation Scores for Benign End Stage Liver Diseases Recipients].

Emergent Right Lobe Adult-to-adult Living-Donor Liver Transplantation for High Model for End-Stage Liver Disease Score Severe Hepatitis.

Liver Transplantation in Acute-on-chronic Liver Failure Patients with High Model for End-Stage Liver Disease (MELD) Scores: a Single Center Experience of 100 Consecutive Cases.

Clinical Curative Effect and Safety Evaluation of General Surgical Treatment of End-Stage Liver Disease

Clinical Analysis Of Liver Transplantation For Benign Liver Tumor

[Therapeutic Effect of Liver Transplantation on Acute Liver Failure].

A study on the timing of liver transplantation and factors influencing prognosis in patients of acute liver failure

Impact of Pretransplant MELD Score on Posttransplant Outcome in Orthotopic Liver Transplantation for Patients with Acute-on-chronic Hepatitis B Liver Failure.

Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?

Dynamic evaluation based on acute-on-chronic liver failure predicts survival of patients after liver transplantation: a cohort study

Long-term Survival after Liver Transplantation for Benign End-Stage Liver Disease in Adults

Survival status and risk factors of post-transplantation patients with end-stage liver disease

Selection and Timing of Liver Transplantation for Benign End-Stage Liver Disease

Therapeutic Effectiveness of Liver Transplantation: a Single Center Study of 203 Consecutive Cases

[Adult Living Donor Liver Transplantation Using Right Lobe for Severe Hepatitis in Emergency: a Report of 9 Cases].

[Analysis of 565 Cases of Liver Transplantation at a Single Transplantation Center].

[Liver Transplantation for Hepatocellular Carcinoma: Prognostic Analysis of 89 Cases].